Sponsor or institution

Clinical trials and research at Xinjiang Medical University

As of November 12, 2026, Find a Trial lists 6 clinical trials run by Xinjiang Medical University that are recruiting, in China. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Long-term outcomes after treatment for primary aldosteronism — Chengdu, Sichuan and 1 other locations Recruiting Jan 30, 2026
Primary aldosteronism and thinking/memory problems — Chengdu, Sichuan and 1 other locations Recruiting Dec 26, 2025
Evaluating a new treatment for primary aldosteronism using adrenal artery embolization — Ürümqi, Xinjiang Recruiting Jul 22, 2024
Comparing two treatments for primary aldosteronism — Ürümqi, Xinjiang Recruiting Jul 22, 2024
Observing clinical outcomes in patients with cardiovascular diseases — Ürümqi, Xinjiang Recruiting Jun 14, 2024
Monitoring and improving hypertension management in Xinjiang — Ürümqi, Xinjiang Recruiting Dec 7, 2023

All recruiting trials (6)

Quick answers

How many clinical trials run by Xinjiang Medical University are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.